Program Area: Social Research, Policy, and Practice
John Omura, MD, MPH
Medical Officer
Healthy Aging Branch
CDC
Atlanta, Georgia, United States
Eva Jackson, MPH, CHES
Associate Director of the Healthy Brain Initiative
Healthy Aging Branch
Alzheimer's Association
Chicago, Illinois, United States
Kelly O'Brien, MPA
Executive Director
Brain Health Partnership
UsAgainstAlzheimer's
Chicago, Illinois, United States
Lisa McGuire, PhD, FGSA
Lead, Alzheimer’s Disease and Healthy Aging Program
Healthy Aging Branch
CDC
Atlanta, Georgia, United States
John Omura, MD, MPH
Medical Officer
Healthy Aging Branch
CDC
Atlanta, Georgia, United States
Benjamin Olivari, MPH
Health Scientist
Healthy Aging Branch
CDC
Atlanta, Georgia, United States
Elizabeth Head, MPH
Deputy Director, Injury Prevention Program
Injury Prevention Program
Georgia Department of Public Health
Atlanta, Georgia, United States
Matthew Baumgart
Vice President, Health Policy
Care and Support & Public Policy
Alzheimer's Association
New York, New York, United States
A growing body of evidence has identified potential modifiable risk factors for Alzheimer’s disease and related dementias (ADRD). In 2021, the National Plan to Address Alzheimer's Disease (National Plan) included a new goal to promote healthy aging and address risk factors to help delay onset or slow progression of ADRD. Applying a robust public health approach to ADRD risk reduction can help achieve meaningful progress at the population level. The activities outlined in the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (P.L. 115-406) are designed to create a uniform national public health infrastructure with a focus on various issues including risk reduction. The purpose of this session is to illustrate a public health approach to ADRD risk reduction, including its current status along with future directions and priorities. An overview of the National Plan’s new goal regarding ADRD risk reduction (McGuire) and data highlighting the current burden of key modifiable risk factors in the United States along with important disparities (Omura) will be presented. Holt will describe how ADRD risk reduction is integrated into the work of BOLD funding recipients, and Head will present experiences implementing public health activities that support ADRD risk reduction in the field along with successes and lessons learned. Finally, priorities and future directions for a public health approach to ADRD risk reduction will be presented from the perspective of the CDC’s Building Our Largest Dementia Infrastructure Public Health Center of Excellence on Dementia Risk Reduction (Baumgart).
Individual Symposium Abstract First Author: Lisa C. McGuire, PhD, FGSA – CDC
Individual Symposium Abstract First Author: John D. Omura, MD, MPH – CDC
Individual Symposium Abstract First Author: Benjamin Olivari, MPH – CDC
Individual Symposium Abstract First Author: Elizabeth N. Head, MPH – Georgia Department of Public Health
Individual Symposium Abstract First Author: Matthew Baumgart – Alzheimer's Association